Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|May 17, 2024
Design and synthesis of novel thiazole-derivatives as potent ALK5 inhibitorsMai Arai, Mitsuharu Hanada, Hideki Moriyama, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2026
Discovery of orally available benzimidazole-based STING antagonists with in vivo activityTakao Kiyoi, Hirokazu Matsumoto, Shiori Takamatsu, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2025
Identification of small molecule activators targeting TYK2 pseudokinase domainHirokazu Matsumoto, Tien-Cheng Wang, Haruka Taniguchi, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Tryptamine-based human beta3-adrenergic receptor agonists. Part 2: SAR of the methylene derivativesMasaaki Sawa, Hirotaka Tateishi, Kazuhiro Mizuno, et al.
Journal of Medicinal Chemistry|October 5, 2021
Discovery of AS-0141, a Potent and Selective Inhibitor of CDC7 Kinase for the Treatment of Solid CancersTakayuki Irie, Tokiko Asami, Ayako Sawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2007
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cellsTsui-Ling Hsu, Sarah R Hanson, Kuniyuki Kishikawa, et al.
Journal of Medicinal Chemistry|March 20, 2025
Discovery of HM-279, a Potent Inhibitor of ALK5 for Improving Therapeutic Efficacy of Cancer ImmunotherapyMai Arai, Mitsuharu Hanada, Haruka Taniguchi, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Tryptamine-based human beta3-adrenergic receptor agonists. Part 1: SAR studies of the 7-position of the indole ringKazuhiro Mizuno, Masaaki Sawa, Hiroshi Harada, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2024
Design and synthesis of novel triazine derivatives as antimalarial agentsYuko Asamitsu, Aki Ishiyama, Yui Iwamae, et al.
Pageof 7